A detailed history of Cookson Peirce & CO Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, Cookson Peirce & CO Inc holds 20,826 shares of ARDX stock, worth $110,169. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,826
Previous 30,000 30.58%
Holding current value
$110,169
Previous $186,000 18.28%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$6.05 - $9.74 $55,502 - $89,354
-9,174 Reduced 30.58%
20,826 $152,000
Q4 2023

Jan 30, 2024

BUY
$3.29 - $6.64 $98,700 - $199,200
30,000 New
30,000 $186,000
Q1 2023

May 03, 2023

BUY
$2.68 - $4.79 $134,000 - $239,500
50,000 New
50,000 $240,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $818M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Cookson Peirce & CO Inc Portfolio

Follow Cookson Peirce & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cookson Peirce & CO Inc with notifications on news.